SecBot SecBot
8-K ·Filed Jul 6, 2026

HYEX

HEALTHY EXTRACTS INC.
BEARISH
Impact 5/10
Horizonweeks Processed3mo ago SEC0001096906-26-001054
8-K context-dependent: Items 5.02
Actionable Insight ▼ Bearish

The sudden resignation of the President and COO without a named successor signals potential instability. Monitor for any subsequent hiring announcements or further C-suite departures, as prolonged vacancies could disrupt business execution.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
HYEX ▼ -13.93% at T+60d
SHORT call ✓ call won +13.93% · α vs SPY +17.02% · entry $1.22 → $1.05
Entry = T+0 close
Jul 6, 2026
via day close
T+1d
+6.56%
call -6.56% · α -6.87%
$1.30
settled 4mo ago
T+5d
+43.44%
call -43.44% · α -42.89%
$1.75
settled 4mo ago
T+20d
+13.73%
call -13.73% · α -10.57%
$1.39
settled 3mo ago
T+60d
-13.93%
call +13.93% · α +17.02%
$1.05
settled 28d ago

Price Chart

Loading chart...

Executive Summary

Kevin Duke Pitts resigned as President, Chief Operating Officer, and board member effective July 1, 2026. No replacement has been named and both positions will remain vacant indefinitely, raising governance and operational concerns for this small OTC life sciences company.

Key Facts

  • Kevin Duke Pitts resigned as President, COO, and Board member on July 1, 2026.
  • The positions of President and COO will remain vacant until further notice; no replacement has been named.
  • The resignation was classified as a resignation, not a retirement.

Financial Impact

No financial figures reported; the departure creates a leadership gap in operations and board oversight at a small OTC company.

managementgovernance

Risk Factors

  • Lack of operational leadership may hinder execution and strategic direction.
  • Potential further departures or management instability could emerge.
  • Vacant board seat reduces governance oversight until filled.

Market Snapshot

Exchange
OTC
Sector
Medicinal Chemicals & Botanical Products

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001096906-26-001054
Document: 0001096906-26-001054-index-headers.html0001096906-26-001054
Document: 0001096906-26-001054-index.html0001096906-26-001054
Document: 0001096906-26-001054.txt0001096906-26-001054
4 reports for HYEX
Performance horizon
Filters
Rows
Reports for HYEX — sortable, filterable
TypeNow
Sep 18, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$1.17awaiting T+60—$1.29 (+9.96%)
Jul 13, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$1.75 $1.05▼ −40.00%▼ −43.63%$1.29 (−26.29%)
Jul 6, 2026
16w ago
8-K
BEARISH ★ 5/10
$1.22 $1.05▲ +13.93%▲ +17.02%$1.29 (−5.74%)
May 18, 2026
23w ago
8-K
NEUTRAL ★ 5/10
$1.25 $1.50▲ +19.66%▲ +14.80%$1.29 (+2.90%)
Showing 4 of 4

US Market Status

Market Open — Closes in 5h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 6, 2026